Exact Mass: 491.324671

Exact Mass Matches: 491.324671

Found 298 metabolites which its exact mass value is equals to given mass value 491.324671, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   
   

Bardoxolone

Bardoxolone

C31H41NO4 (491.30354260000007)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C29574 - Nitric Oxide Synthase Inhibitor C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

   

(7E,10E,13E,16E)-3-Hydroxydocosa-7,10,13,16-tetraenoylcarnitine

3-[(3-hydroxydocosa-7,10,13,16-tetraenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H49NO5 (491.36105440000006)


(7E,10E,13E,16E)-3-Hydroxydocosa-7,10,13,16-tetraenoylcarnitine is an acylcarnitine. More specifically, it is an (7E,10E,13E,16E)-3-hydroxydocosa-7,10,13,16-tetraenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (7E,10E,13E,16E)-3-Hydroxydocosa-7,10,13,16-tetraenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (7E,10E,13E,16E)-3-Hydroxydocosa-7,10,13,16-tetraenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(10E)-11-(3,4-Dimethyl-5-pentylfuran-2-yl)undec-10-enoylcarnitine

3-{[11-(3,4-dimethyl-5-pentylfuran-2-yl)undec-10-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

C29H49NO5 (491.36105440000006)


(10E)-11-(3,4-dimethyl-5-pentylfuran-2-yl)undec-10-enoylcarnitine is an acylcarnitine. More specifically, it is an (10E)-11-(3,4-dimethyl-5-pentylfuran-2-yl)undec-10-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (10E)-11-(3,4-dimethyl-5-pentylfuran-2-yl)undec-10-enoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (10E)-11-(3,4-dimethyl-5-pentylfuran-2-yl)undec-10-enoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

11-{3,4-Dimethyl-5-[(1E)-pent-1-en-1-yl]furan-2-yl}undecanoylcarnitine

3-({11-[3,4-dimethyl-5-(pent-1-en-1-yl)furan-2-yl]undecanoyl}oxy)-4-(trimethylazaniumyl)butanoate

C29H49NO5 (491.36105440000006)


11-{3,4-dimethyl-5-[(1E)-pent-1-en-1-yl]furan-2-yl}undecanoylcarnitine is an acylcarnitine. More specifically, it is an 11-{3,4-dimethyl-5-[(1E)-pent-1-en-1-yl]furan-2-yl}undecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 11-{3,4-dimethyl-5-[(1E)-pent-1-en-1-yl]furan-2-yl}undecanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 11-{3,4-dimethyl-5-[(1E)-pent-1-en-1-yl]furan-2-yl}undecanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Docosahexaenoyl Tyrosine

2-[(1-Hydroxydocosa-4,7,10,13,16,19-hexaen-1-ylidene)amino]-3-(4-hydroxyphenyl)propanoate

C31H41NO4 (491.30354260000007)


N-docosahexaenoyl tyrosine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Tyrosine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Tyrosine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Tyrosine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Chenodeoxycholylvaline

2-(4-{5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)-3-methylbutanoic acid

C29H49NO5 (491.36105440000006)


Chenodeoxycholylvaline belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholylvaline consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Valine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholylvaline, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholylvaline appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Deoxycholylvaline

2-[(4-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}-1-hydroxypentylidene)amino]-3-methylbutanoate

C29H49NO5 (491.36105440000006)


Deoxycholylvaline belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholylvaline consists of the bile acid deoxycholic acid conjugated to the amino acid Valine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholylvaline, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholylvaline appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Bardoxolone

11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-octadecahydropicene-4a-carboxylic acid

C31H41NO4 (491.30354260000007)


   

Lidoflazine

2-{4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl}-N-(2,6-dimethylphenyl)ethanimidic acid

C30H35F2N3O (491.2748044)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C - Cardiovascular system > C08 - Calcium channel blockers > C08E - Non-selective calcium channel blockers D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   
   
   
   
   
   
   
   
   

3,9,14,15alpha,16beta,20-Hexahydroxy-A-nor-5beta-cevan-3alpha-carbonsaeure-9-lacton|3,9,14,15alpha,16beta,20-hexahydroxy-A-nor-5beta-cevane-3alpha-carboxylic acid-9-lactone

3,9,14,15alpha,16beta,20-Hexahydroxy-A-nor-5beta-cevan-3alpha-carbonsaeure-9-lacton|3,9,14,15alpha,16beta,20-hexahydroxy-A-nor-5beta-cevane-3alpha-carboxylic acid-9-lactone

C27H41NO7 (491.28828760000005)


   
   

Lipstatin

(2S,4Z,7Z)-1-[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]-4,7-tridecadien-2-yl N-formyl-L-leucinate

C29H49NO5 (491.36105440000006)


   
   

(3R)-3-hydroxy-12-{(1S,4S)-4-[(1S)-1-hydroxyethyl]-pyrrolidin-1-yl}-dodecanoic acid-3-O-beta-D-glucopyranoside|morusimic acid A

(3R)-3-hydroxy-12-{(1S,4S)-4-[(1S)-1-hydroxyethyl]-pyrrolidin-1-yl}-dodecanoic acid-3-O-beta-D-glucopyranoside|morusimic acid A

C24H45NO9 (491.30941600000006)


   

(2S,3Z)-5-{[(2R,3R,5S,6S)-6-{(2E,4E)-5-[(3R,5S,7S)-7-hydroxy-7-methyl-1,6-dioxaspiro[2.5]oct-5-yl]-3-methylpenta-2,4-dien-1-yl}-2,5-dimethyltetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate

(2S,3Z)-5-{[(2R,3R,5S,6S)-6-{(2E,4E)-5-[(3R,5S,7S)-7-hydroxy-7-methyl-1,6-dioxaspiro[2.5]oct-5-yl]-3-methylpenta-2,4-dien-1-yl}-2,5-dimethyltetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate

C27H41NO7 (491.28828760000005)


   

3beta-hydroxy-(22E,24R)-ergosta-5,8(14),22-triene-1,2-dicarboxylic acid imide|ergosterimide

3beta-hydroxy-(22E,24R)-ergosta-5,8(14),22-triene-1,2-dicarboxylic acid imide|ergosterimide

C32H45NO3 (491.339926)


   
   
   

Valine conjugated chenodeoxycholic acid

Valine conjugated chenodeoxycholic acid

C29H49NO5 (491.36105440000006)


   

Ala Phe Arg Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C23H37N7O5 (491.2856032)


   

Ala Phe Val Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Ala Arg Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C23H37N7O5 (491.2856032)


   

Ala Arg Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Ala Val Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Ala Val Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Phe Ala Arg Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C23H37N7O5 (491.2856032)


   

Phe Ala Val Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Phe Gly Ile Arg

(2S)-2-[(2S,3S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Phe Gly Leu Arg

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Phe Gly Arg Ile

(2S,3S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C23H37N7O5 (491.2856032)


   

Phe Gly Arg Leu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C23H37N7O5 (491.2856032)


   

Phe Ile Gly Arg

(2S)-2-{2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]acetamido}-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Phe Ile Arg Gly

2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]acetic acid

C23H37N7O5 (491.2856032)


   

Phe Lys Val Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-3-methylbutanamido]-3-methylbutanoic acid

C25H41N5O5 (491.31075360000006)


   

Phe Leu Gly Arg

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]acetamido}-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Phe Leu Arg Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]acetic acid

C23H37N7O5 (491.2856032)


   

Phe Arg Ala Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]propanamido]-3-methylbutanoic acid

C23H37N7O5 (491.2856032)


   

Phe Arg Gly Ile

(2S,3S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]acetamido}-3-methylpentanoic acid

C23H37N7O5 (491.2856032)


   

Phe Arg Gly Leu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]acetamido}-4-methylpentanoic acid

C23H37N7O5 (491.2856032)


   

Phe Arg Ile Gly

2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]acetic acid

C23H37N7O5 (491.2856032)


   

Phe Arg Leu Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]acetic acid

C23H37N7O5 (491.2856032)


   

Phe Arg Val Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]propanoic acid

C23H37N7O5 (491.2856032)


   

Phe Val Ala Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]propanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Phe Val Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]hexanamido]-3-methylbutanoic acid

C25H41N5O5 (491.31075360000006)


   

Phe Val Arg Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]propanoic acid

C23H37N7O5 (491.2856032)


   

Phe Val Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-methylbutanamido]hexanoic acid

C25H41N5O5 (491.31075360000006)


   

Gly Phe Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Gly Phe Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Gly Phe Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C23H37N7O5 (491.2856032)


   

Gly Phe Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C23H37N7O5 (491.2856032)


   

Gly Ile Phe Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Gly Ile Arg Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Gly Leu Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Gly Leu Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Gly Arg Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C23H37N7O5 (491.2856032)


   

Gly Arg Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C23H37N7O5 (491.2856032)


   

Gly Arg Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Gly Arg Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Ile Phe Gly Arg

(2S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]acetamido}-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Ile Phe Arg Gly

2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]acetic acid

C23H37N7O5 (491.2856032)


   

Ile Gly Phe Arg

(2S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Ile Gly Arg Phe

(2S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Ile Lys Met Thr

(2S,3R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanoic acid

C21H41N5O6S (491.2777406000001)


   

Ile Lys Thr Met

(2S)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O6S (491.2777406000001)


   

Ile Met Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-(methylsulfanyl)butanamido]hexanamido]-3-hydroxybutanoic acid

C21H41N5O6S (491.2777406000001)


   

Ile Met Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]hexanoic acid

C21H41N5O6S (491.2777406000001)


   

Ile Arg Phe Gly

2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]acetic acid

C23H37N7O5 (491.2856032)


   

Ile Arg Gly Phe

(2S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]acetamido}-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Ile Thr Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O6S (491.2777406000001)


   

Ile Thr Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Phe Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-methylbutanoic acid

C25H41N5O5 (491.31075360000006)


   

Lys Ile Met Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Ile Thr Met

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Leu Met Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Leu Thr Met

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Met Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Met Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Met Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Met Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Thr Ile Met

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Thr Leu Met

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Thr Met Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Thr Met Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanoic acid

C21H41N5O6S (491.2777406000001)


   

Lys Val Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C25H41N5O5 (491.31075360000006)


   

Lys Val Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C25H41N5O5 (491.31075360000006)


   

Leu Phe Gly Arg

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]acetamido}-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Leu Phe Arg Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]acetic acid

C23H37N7O5 (491.2856032)


   

Leu Gly Phe Arg

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Leu Gly Arg Phe

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Leu Lys Met Thr

(2S,3R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanoic acid

C21H41N5O6S (491.2777406000001)


   

Leu Lys Thr Met

(2S)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O6S (491.2777406000001)


   

Leu Met Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-(methylsulfanyl)butanamido]hexanamido]-3-hydroxybutanoic acid

C21H41N5O6S (491.2777406000001)


   

Leu Met Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]hexanoic acid

C21H41N5O6S (491.2777406000001)


   

Leu Arg Phe Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]acetic acid

C23H37N7O5 (491.2856032)


   

Leu Arg Gly Phe

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]acetamido}-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Leu Thr Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O6S (491.2777406000001)


   

Leu Thr Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C21H41N5O6S (491.2777406000001)


   

Met Ile Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylpentanamido]hexanamido]-3-hydroxybutanoic acid

C21H41N5O6S (491.2777406000001)


   

Met Ile Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylpentanamido]-3-hydroxybutanamido]hexanoic acid

C21H41N5O6S (491.2777406000001)


   

Met Lys Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C21H41N5O6S (491.2777406000001)


   

Met Lys Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C21H41N5O6S (491.2777406000001)


   

Met Lys Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C21H41N5O6S (491.2777406000001)


   

Met Lys Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C21H41N5O6S (491.2777406000001)


   

Met Leu Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-methylpentanamido]hexanamido]-3-hydroxybutanoic acid

C21H41N5O6S (491.2777406000001)


   

Met Leu Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-methylpentanamido]-3-hydroxybutanamido]hexanoic acid

C21H41N5O6S (491.2777406000001)


   

Met Thr Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]-3-methylpentanamido]hexanoic acid

C21H41N5O6S (491.2777406000001)


   

Met Thr Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]hexanamido]-3-methylpentanoic acid

C21H41N5O6S (491.2777406000001)


   

Met Thr Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]hexanamido]-4-methylpentanoic acid

C21H41N5O6S (491.2777406000001)


   

Met Thr Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]-4-methylpentanamido]hexanoic acid

C21H41N5O6S (491.2777406000001)


   

Arg Ala Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C23H37N7O5 (491.2856032)


   

Arg Ala Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Arg Phe Ala Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]propanamido]-3-methylbutanoic acid

C23H37N7O5 (491.2856032)


   

Arg Phe Gly Ile

(2S,3S)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]acetamido}-3-methylpentanoic acid

C23H37N7O5 (491.2856032)


   

Arg Phe Gly Leu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]acetamido}-4-methylpentanoic acid

C23H37N7O5 (491.2856032)


   

Arg Phe Ile Gly

2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-methylpentanamido]acetic acid

C23H37N7O5 (491.2856032)


   

Arg Phe Leu Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-4-methylpentanamido]acetic acid

C23H37N7O5 (491.2856032)


   

Arg Phe Val Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-methylbutanamido]propanoic acid

C23H37N7O5 (491.2856032)


   

Arg Gly Phe Ile

(2S,3S)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-phenylpropanamido]-3-methylpentanoic acid

C23H37N7O5 (491.2856032)


   

Arg Gly Phe Leu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-phenylpropanamido]-4-methylpentanoic acid

C23H37N7O5 (491.2856032)


   

Arg Gly Ile Phe

(2S)-2-[(2S,3S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-methylpentanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Arg Gly Leu Phe

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-4-methylpentanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Arg Ile Phe Gly

2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-phenylpropanamido]acetic acid

C23H37N7O5 (491.2856032)


   

Arg Ile Gly Phe

(2S)-2-{2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]acetamido}-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Arg Leu Phe Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-phenylpropanamido]acetic acid

C23H37N7O5 (491.2856032)


   

Arg Leu Gly Phe

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]acetamido}-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Arg Val Ala Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]propanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Arg Val Phe Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-phenylpropanamido]propanoic acid

C23H37N7O5 (491.2856032)


   

Thr Ile Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O6S (491.2777406000001)


   

Thr Ile Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C21H41N5O6S (491.2777406000001)


   

Thr Lys Ile Met

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O6S (491.2777406000001)


   

Thr Lys Leu Met

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O6S (491.2777406000001)


   

Thr Lys Met Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanoic acid

C21H41N5O6S (491.2777406000001)


   

Thr Lys Met Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanoic acid

C21H41N5O6S (491.2777406000001)


   

Thr Leu Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O6S (491.2777406000001)


   

Thr Leu Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C21H41N5O6S (491.2777406000001)


   

Thr Met Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanamido]hexanoic acid

C21H41N5O6S (491.2777406000001)


   

Thr Met Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]hexanamido]-3-methylpentanoic acid

C21H41N5O6S (491.2777406000001)


   

Thr Met Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]hexanamido]-4-methylpentanoic acid

C21H41N5O6S (491.2777406000001)


   

Thr Met Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanamido]hexanoic acid

C21H41N5O6S (491.2777406000001)


   

Val Ala Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Val Ala Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Val Phe Ala Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]propanamido]-5-carbamimidamidopentanoic acid

C23H37N7O5 (491.2856032)


   

Val Phe Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]hexanamido]-3-methylbutanoic acid

C25H41N5O5 (491.31075360000006)


   

Val Phe Arg Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]propanoic acid

C23H37N7O5 (491.2856032)


   

Val Phe Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-methylbutanamido]hexanoic acid

C25H41N5O5 (491.31075360000006)


   

Val Lys Phe Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C25H41N5O5 (491.31075360000006)


   

Val Lys Val Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C25H41N5O5 (491.31075360000006)


   

Val Arg Ala Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]propanamido]-3-phenylpropanoic acid

C23H37N7O5 (491.2856032)


   

Val Arg Phe Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]propanoic acid

C23H37N7O5 (491.2856032)


   

Val Val Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-phenylpropanamido]hexanoic acid

C25H41N5O5 (491.31075360000006)


   

Val Val Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]hexanamido]-3-phenylpropanoic acid

C25H41N5O5 (491.31075360000006)


   
   
   
   

(5R,11R,13S,14S,17S)-11-[4-(Dimethylamino)phenyl]-13-methyl-17-(1 -propyn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydrospiro[cyc lopenta[a]phenanthrene-3,2-[1,3]dioxolane]-5,17(4H)-diol

(5R,11R,13S,14S,17S)-11-[4-(Dimethylamino)phenyl]-13-methyl-17-(1 -propyn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydrospiro[cyc lopenta[a]phenanthrene-3,2-[1,3]dioxolane]-5,17(4H)-diol

C31H41NO4 (491.30354260000007)


   

Ethyl Violet

Ethyl Violet

C31H42ClN3 (491.30670820000006)


D004396 - Coloring Agents > D012394 - Rosaniline Dyes

   

2,2,5,5-Tetramethyl-1-((11-(Triethoxysilyl)Undecyl)Oxy)-1,2,5-Azadisilolidine

2,2,5,5-Tetramethyl-1-((11-(Triethoxysilyl)Undecyl)Oxy)-1,2,5-Azadisilolidine

C23H53NO4Si3 (491.32822180000005)


   

NNC-55-0396 Free base

NNC-55-0396 Free base

C30H38FN3O2 (491.29479)


   

Lidoflazine

Lidoflazine

C30H35F2N3O (491.2748044)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C - Cardiovascular system > C08 - Calcium channel blockers > C08E - Non-selective calcium channel blockers D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   
   
   

(7E,10E,13E,16E)-3-Hydroxydocosa-7,10,13,16-tetraenoylcarnitine

(7E,10E,13E,16E)-3-Hydroxydocosa-7,10,13,16-tetraenoylcarnitine

C29H49NO5 (491.36105440000006)


   

(10E)-11-(3,4-Dimethyl-5-pentylfuran-2-yl)undec-10-enoylcarnitine

(10E)-11-(3,4-Dimethyl-5-pentylfuran-2-yl)undec-10-enoylcarnitine

C29H49NO5 (491.36105440000006)


   

11-{3,4-Dimethyl-5-[(1E)-pent-1-en-1-yl]furan-2-yl}undecanoylcarnitine

11-{3,4-Dimethyl-5-[(1E)-pent-1-en-1-yl]furan-2-yl}undecanoylcarnitine

C29H49NO5 (491.36105440000006)


   

3-[4-[(8R,9R,10R)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

3-[4-[(8R,9R,10R)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

C30H41N3O3 (491.3147756000001)


   

1-[(4R,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

1-[(4R,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

C25H41N5O5 (491.31075360000006)


   

1-[(4S,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

1-[(4S,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

C25H41N5O5 (491.31075360000006)


   

1-[(4S,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

1-[(4S,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

C25H41N5O5 (491.31075360000006)


   

(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide

(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide

C25H41N5O5 (491.31075360000006)


   

(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide

(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide

C25H41N5O5 (491.31075360000006)


   

(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

C25H41N5O5 (491.31075360000006)


   

(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

C25H41N5O5 (491.31075360000006)


   

(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

C25H41N5O5 (491.31075360000006)


   

3-[4-[(8R,9R,10S)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

3-[4-[(8R,9R,10S)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

C30H41N3O3 (491.3147756000001)


   

3-[4-[(8S,9S,10S)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

3-[4-[(8S,9S,10S)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

C30H41N3O3 (491.3147756000001)


   

3-[4-[(8S,9R,10R)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

3-[4-[(8S,9R,10R)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

C30H41N3O3 (491.3147756000001)


   

4-[4-[(8R,9S,10R)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

4-[4-[(8R,9S,10R)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

C30H41N3O3 (491.3147756000001)


   

(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propan-2-yl-2-(3-pyridinylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propan-2-yl-2-(3-pyridinylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

C28H37N5O3 (491.28962520000005)


   

(2R)-2-[(4S,5S)-5-[[cyclopentylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

(2R)-2-[(4S,5S)-5-[[cyclopentylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C26H41N3O4S (491.2817626000001)


   

[(1S)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-(4-oxanylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

[(1S)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-(4-oxanylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C29H37N3O4 (491.27839220000004)


   

1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-9-[[oxo-(propan-2-ylamino)methyl]amino]-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-9-[[oxo-(propan-2-ylamino)methyl]amino]-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C25H41N5O5 (491.31075360000006)


   

(2S)-2-[(4R,5R)-5-[[cyclopentylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

(2S)-2-[(4R,5R)-5-[[cyclopentylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C26H41N3O4S (491.2817626000001)


   

1-[(4S,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

1-[(4S,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

C25H41N5O5 (491.31075360000006)


   

1-[(4R,7R,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

1-[(4R,7R,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

C25H41N5O5 (491.31075360000006)


   

1-[(4R,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

1-[(4R,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

C25H41N5O5 (491.31075360000006)


   

1-[(4R,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

1-[(4R,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

C25H41N5O5 (491.31075360000006)


   

(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide

(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide

C25H41N5O5 (491.31075360000006)


   

(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide

(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide

C25H41N5O5 (491.31075360000006)


   

(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide

(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide

C25H41N5O5 (491.31075360000006)


   

(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide

(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide

C25H41N5O5 (491.31075360000006)


   

(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

C25H41N5O5 (491.31075360000006)


   

(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

C25H41N5O5 (491.31075360000006)


   

(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

C25H41N5O5 (491.31075360000006)


   

(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

C25H41N5O5 (491.31075360000006)


   

(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-14-[[oxo-(propan-2-ylamino)methyl]amino]-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

C25H41N5O5 (491.31075360000006)


   

3-[4-[(8S,9S,10R)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

3-[4-[(8S,9S,10R)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

C30H41N3O3 (491.3147756000001)


   

3-[4-[(8R,9S,10R)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

3-[4-[(8R,9S,10R)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

C30H41N3O3 (491.3147756000001)


   

3-[4-[(8R,9S,10S)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

3-[4-[(8R,9S,10S)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

C30H41N3O3 (491.3147756000001)


   

3-[4-[(8S,9R,10S)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

3-[4-[(8S,9R,10S)-10-(hydroxymethyl)-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide

C30H41N3O3 (491.3147756000001)


   

(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-(2-pyridinylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-(2-pyridinylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

C28H37N5O3 (491.28962520000005)


   

(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-(2-pyridinylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-(2-pyridinylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

C28H37N5O3 (491.28962520000005)


   

[(1R)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-(4-oxanylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

[(1R)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-(4-oxanylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C29H37N3O4 (491.27839220000004)


   

(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propan-2-yl-2-(3-pyridinylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propan-2-yl-2-(3-pyridinylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

C28H37N5O3 (491.28962520000005)


   
   
   
   
   
   
   
   
   
   
   
   
   

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C25H50NO6P (491.33755700000006)


   

2-aminoethyl [2-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propyl] hydrogen phosphate

2-aminoethyl [2-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propyl] hydrogen phosphate

C25H50NO6P (491.33755700000006)


   

[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H46NO7P (491.3011736)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z)-nonadeca-9,12-dienoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z)-nonadeca-9,12-dienoate

C24H46NO7P (491.3011736)


   

(E)-3-hydroxy-2-(2-hydroxydodecanoylamino)tridec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxydodecanoylamino)tridec-4-ene-1-sulfonic acid

C25H49NO6S (491.3280414000001)


   

3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]undecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]undecane-1-sulfonic acid

C25H49NO6S (491.3280414000001)


   

(E)-3-hydroxy-2-(2-hydroxytridecanoylamino)dodec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxytridecanoylamino)dodec-4-ene-1-sulfonic acid

C25H49NO6S (491.3280414000001)


   

3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]dodecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]dodecane-1-sulfonic acid

C25H49NO6S (491.3280414000001)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] acetate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] acetate

C24H46NO7P (491.3011736)


   

3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]tridecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]tridecane-1-sulfonic acid

C25H49NO6S (491.3280414000001)


   

3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]decane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]decane-1-sulfonic acid

C25H49NO6S (491.3280414000001)


   

(E)-3-hydroxy-2-(2-hydroxytetradecanoylamino)undec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxytetradecanoylamino)undec-4-ene-1-sulfonic acid

C25H49NO6S (491.3280414000001)


   

(E)-3-hydroxy-2-(2-hydroxypentadecanoylamino)dec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxypentadecanoylamino)dec-4-ene-1-sulfonic acid

C25H49NO6S (491.3280414000001)


   

2-(Decanoylamino)-3-hydroxyhexadecane-1-sulfonic acid

2-(Decanoylamino)-3-hydroxyhexadecane-1-sulfonic acid

C26H53NO5S (491.36442480000005)


   

3-Hydroxy-2-(undecanoylamino)pentadecane-1-sulfonic acid

3-Hydroxy-2-(undecanoylamino)pentadecane-1-sulfonic acid

C26H53NO5S (491.36442480000005)


   

3-Hydroxy-2-(tetradecanoylamino)dodecane-1-sulfonic acid

3-Hydroxy-2-(tetradecanoylamino)dodecane-1-sulfonic acid

C26H53NO5S (491.36442480000005)


   

2-(Dodecanoylamino)-3-hydroxytetradecane-1-sulfonic acid

2-(Dodecanoylamino)-3-hydroxytetradecane-1-sulfonic acid

C26H53NO5S (491.36442480000005)


   

3-Hydroxy-2-(pentadecanoylamino)undecane-1-sulfonic acid

3-Hydroxy-2-(pentadecanoylamino)undecane-1-sulfonic acid

C26H53NO5S (491.36442480000005)


   

2-(Hexadecanoylamino)-3-hydroxydecane-1-sulfonic acid

2-(Hexadecanoylamino)-3-hydroxydecane-1-sulfonic acid

C26H53NO5S (491.36442480000005)


   

3-Hydroxy-2-(tridecanoylamino)tridecane-1-sulfonic acid

3-Hydroxy-2-(tridecanoylamino)tridecane-1-sulfonic acid

C26H53NO5S (491.36442480000005)


   

N-(decanoyl)-4E-pentadecasphingenine-1-phosphate

N-(decanoyl)-4E-pentadecasphingenine-1-phosphate

C25H50NO6P (491.33755700000006)


   
   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] propanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] propanoate

C24H46NO7P (491.3011736)


   
   

2-[[(4E,8E)-2-(heptanoylamino)-3-hydroxydodeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(heptanoylamino)-3-hydroxydodeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H48N2O6P+ (491.3249818)


   

2-[[(4E,8E)-2-(butanoylamino)-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(butanoylamino)-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H48N2O6P+ (491.3249818)


   

2-[[(4E,8E)-2-acetamido-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-acetamido-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H48N2O6P+ (491.3249818)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentanoylamino)tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentanoylamino)tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C24H48N2O6P+ (491.3249818)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(propanoylamino)hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(propanoylamino)hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C24H48N2O6P+ (491.3249818)


   

2-[[(4E,8E)-2-(hexanoylamino)-3-hydroxytrideca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(hexanoylamino)-3-hydroxytrideca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H48N2O6P+ (491.3249818)


   
   

lysophosphatidylcholine 16:2

lysophosphatidylcholine 16:2

C24H46NO7P (491.3011736)


A lysophosphatidylcholine in which the remaining acyl group contains 16 carbons and 2 double bonds. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.

   

N-docosenoylsphingosine-1-phosphocholine

N-docosenoylsphingosine-1-phosphocholine

C24H48N2O6P (491.3249818)


A sphingomyelin in which the total number of carbons in the fatty acyl group is 22 with 1 double bond.

   
   

NA-Tyr 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

NA-Tyr 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

C31H41NO4 (491.30354260000007)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[(3r,3ar,4s,5r,11ar)-5-(acetyloxy)-4-hydroxy-10-methyl-2-oxo-3-(piperidin-1-ylmethyl)-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-yl]methyl (2r)-2-methylbutanoate

[(3r,3ar,4s,5r,11ar)-5-(acetyloxy)-4-hydroxy-10-methyl-2-oxo-3-(piperidin-1-ylmethyl)-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-yl]methyl (2r)-2-methylbutanoate

C27H41NO7 (491.28828760000005)


   

(2e,4e,6e,8e,10e,12r,13r,14e,16s)-13-hydroxy-n-[(2s)-1-hydroxypropan-2-yl]-2,10,12,14,16-pentamethyl-18-phenyloctadeca-2,4,6,8,10,14-hexaenimidic acid

(2e,4e,6e,8e,10e,12r,13r,14e,16s)-13-hydroxy-n-[(2s)-1-hydroxypropan-2-yl]-2,10,12,14,16-pentamethyl-18-phenyloctadeca-2,4,6,8,10,14-hexaenimidic acid

C32H45NO3 (491.339926)


   

1,1,4a,8-tetramethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9-oxo-decahydrophenanthren-2-yl 3-hydroxy-3-methylbutanoate

1,1,4a,8-tetramethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9-oxo-decahydrophenanthren-2-yl 3-hydroxy-3-methylbutanoate

C28H45NO6 (491.324671)


   

(2s,4ar,4bs,7e,8r,8as,10ar)-1,1,4a,8-tetramethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9-oxo-decahydrophenanthren-2-yl 3-hydroxy-3-methylbutanoate

(2s,4ar,4bs,7e,8r,8as,10ar)-1,1,4a,8-tetramethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9-oxo-decahydrophenanthren-2-yl 3-hydroxy-3-methylbutanoate

C28H45NO6 (491.324671)


   

n-[(2s)-1-{[(2s,4e,7e)-1-(3-hexyl-4-oxooxetan-2-yl)trideca-4,7-dien-2-yl]oxy}-3-methyl-1-oxopentan-2-yl]carboximidic acid

n-[(2s)-1-{[(2s,4e,7e)-1-(3-hexyl-4-oxooxetan-2-yl)trideca-4,7-dien-2-yl]oxy}-3-methyl-1-oxopentan-2-yl]carboximidic acid

C29H49NO5 (491.36105440000006)


   

1-[(1s,3as,3br,5as,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5r,6r)-4-methoxy-6-methyl-5-(methylamino)oxan-2-yl]oxy}-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]ethanone

1-[(1s,3as,3br,5as,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5r,6r)-4-methoxy-6-methyl-5-(methylamino)oxan-2-yl]oxy}-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]ethanone

C29H49NO5 (491.36105440000006)


   

n-[(2s)-1-{[(2s,4z,7z)-1-[(2s,3s)-3-hexyl-4-oxooxetan-2-yl]trideca-4,7-dien-2-yl]oxy}-4-methyl-1-oxopentan-2-yl]carboximidic acid

n-[(2s)-1-{[(2s,4z,7z)-1-[(2s,3s)-3-hexyl-4-oxooxetan-2-yl]trideca-4,7-dien-2-yl]oxy}-4-methyl-1-oxopentan-2-yl]carboximidic acid

C29H49NO5 (491.36105440000006)


   

7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[1-(2-methyl-1,3-oxazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione

7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[1-(2-methyl-1,3-oxazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione

C27H41NO7 (491.28828760000005)